5.16
Mei Pharma Inc (MEIP) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
-
|
- | - | - | - |
Research and Development |
19.81%
0.369
|
0.308 | 3.163 | - | - |
Costs And Expenses |
19.62%
2.774
|
3.451 | 8.352 | 18.98 | 9.829 |
Operating Income/Loss |
19.62%
-2.774
|
-3.451 | -8.352 | -18.98 | -9.829 |
Nonoperating Income/Loss |
74.03%
0.201
|
0.774 | 0.345 | 0.574 | 0.702 |
Income/Loss From Continuing Operations Before Tax |
3.62%
-2.774
|
-2.677 | -8.007 | -18.41 | -9.829 |
Income/Loss From Continuing Operations After Tax |
3.88%
-2.573
|
-2.677 | -8.007 | -18.41 | -9.127 |
|
3.88%
-2.573
|
-2.677 | -8.007 | -18.41 | -9.127 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.00%
6.663
|
6.663 | 6.663 | - | 6.663 |
Diluted Average Shares |
0.00%
6.663
|
6.663 | 6.663 | - | 6.663 |
Basic Earnings Per Share |
2.50%
-0.39
|
-0.40 | -1.20 | -2.76 | -1.37 |
Diluted Earnings Per Share |
2.50%
-0.39
|
-0.40 | -1.20 | -2.76 | -1.37 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):